Previous close | 231.75 |
Open | 231.22 |
Bid | 231.90 x 800 |
Ask | 231.96 x 900 |
Day's range | 230.80 - 232.69 |
52-week range | 156.72 - 234.68 |
Volume | |
Avg. volume | 1,217,209 |
Market cap | 66.252B |
Beta (5Y monthly) | 1.09 |
PE ratio (TTM) | 42.96 |
EPS (TTM) | 5.40 |
Earnings date | 30 Jul 2024 - 05 Aug 2024 |
Forward dividend & yield | 2.28 (0.98%) |
Ex-dividend date | 18 Jun 2024 |
1y target est | 240.75 |
Baxter's (BAX) receipt of the latest expanded indication for Clinolipid is expected to meet the diverse nutritional needs of patients, ranging from preterm neonates to adults.
Investors are optimistic about Glaukos' (GKOS) strength in its flagship iStent.
Philips' (PHG) software update for Trilogy Evo ventilators is set to mitigate a possible power malfunction and gets FDA Class I recall identification, as it may cause serious harm.